HighVista Strategies LLC - Q3 2023 holdings

$216 Million is the total value of HighVista Strategies LLC's 132 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .

 Value Shares↓ Weighting
CPRI NewCAPRI HOLDINGS LIMITED$4,087,79777,700
+100.0%
1.89%
SPLK NewSPLUNK INC$4,036,50027,600
+100.0%
1.87%
NewSTRUCTURE THERAPEUTICS INCsponsored ads$3,773,02974,832
+100.0%
1.75%
AMED NewAMEDISYS INC$3,665,95039,250
+100.0%
1.70%
IDYA NewIDEAYA BIOSCIENCES INC$3,422,278126,845
+100.0%
1.58%
IMGN NewIMMUNOGEN INC$2,297,532144,772
+100.0%
1.06%
IONS NewIONIS PHARMACEUTICALS INC$2,200,86748,520
+100.0%
1.02%
INSM NewINSMED INC$2,020,00080,000
+100.0%
0.94%
DVAX NewDYNAVAX TECHNOLOGIES CORP$1,964,410133,000
+100.0%
0.91%
MU NewMICRON TECHNOLOGY INC$1,918,44628,200
+100.0%
0.89%
X NewUNITED STATES STL CORP NEW$1,393,39242,900
+100.0%
0.64%
TEVA NewTEVA PHARMACEUTICAL INDS LTDsponsored ads$1,267,860124,300
+100.0%
0.59%
BBIO NewBRIDGEBIO PHARMA INC$1,175,36444,572
+100.0%
0.54%
SLB NewSCHLUMBERGER LTD$1,072,72018,400
+100.0%
0.50%
WDC NewWESTERN DIGITAL CORP.$917,16320,100
+100.0%
0.42%
TPX NewTEMPUR SEALY INTL INC$862,46619,900
+100.0%
0.40%
LLY NewELI LILLY & CO$751,9821,400
+100.0%
0.35%
HLT NewHILTON WORLDWIDE HLDGS INC$720,8644,800
+100.0%
0.33%
CZR NewCAESARS ENTERTAINMENT INC NE$658,17014,200
+100.0%
0.30%
ANTM NewELEVANCE HEALTH INC$609,5881,400
+100.0%
0.28%
UNH NewUNITEDHEALTH GROUP INC$605,0281,200
+100.0%
0.28%
RTX NewRTX CORPORATION$582,9578,100
+100.0%
0.27%
AKRO NewAKERO THERAPEUTICS INC$577,01711,408
+100.0%
0.27%
UBER NewUBER TECHNOLOGIES INC$574,87512,500
+100.0%
0.27%
CPT NewCAMDEN PPTY TRsh ben int$548,5645,800
+100.0%
0.25%
TRU NewTRANSUNION$545,6047,600
+100.0%
0.25%
CERE NewCEREVEL THERAPEUTICS HLDNG I$543,28324,887
+100.0%
0.25%
RVMD NewREVOLUTION MEDICINES INC$498,37818,005
+100.0%
0.23%
ITCI NewINTRA-CELLULAR THERAPIES INC$497,1999,545
+100.0%
0.23%
NewTKO GROUP HOLDINGS INCcl a$496,5425,907
+100.0%
0.23%
GLPG NewGALAPAGOS NVspon adr$471,50413,647
+100.0%
0.22%
PNT NewPOINT BIOPHARMA GLOBAL INC$465,19269,744
+100.0%
0.22%
TAL NewTAL EDUCATION GROUPsponsored ads$458,23350,300
+100.0%
0.21%
FDMT New4D MOLECULAR THERAPEUTICS IN$425,42433,419
+100.0%
0.20%
VERA NewVERA THERAPEUTICS INCcl a$423,66630,902
+100.0%
0.20%
NewNEW ORIENTAL ED & TECHNOLOGYspon adr$374,7206,400
+100.0%
0.17%
PTCT NewPTC THERAPEUTICS INC$296,64113,237
+100.0%
0.14%
MORF NewMORPHIC HLDG INC$235,44610,277
+100.0%
0.11%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC29Q2 20232.9%
VANGUARD INDEX FDS24Q4 201926.4%
APPLE INC24Q4 20192.0%
ISHARES TR22Q3 20187.9%
MICROSOFT CORP21Q3 20232.0%
VISA INC20Q3 20235.8%
INVESCO DB COMMDY INDX TRCK20Q3 202316.6%
VERIZON COMMUNICATIONS INC20Q4 20190.4%
ALIBABA GROUP HLDG LTD19Q3 20237.7%
AMAZON COM INC19Q3 20232.9%

View HighVista Strategies LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HighVista Strategies LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
STG Group, Inc.Sold outFebruary 16, 201600.0%
SAExploration Holdings, Inc.February 12, 201425,0000.2%
Trio Merger Corp.February 14, 2013690,0008.8%

View HighVista Strategies LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View HighVista Strategies LLC's complete filings history.

Compare quarters

Export HighVista Strategies LLC's holdings